Non-nephrotoxic empiric antimicrobial therapy in febrile neutropenic cancer patients
- 31 May 1992
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 28 (4) , 867-870
- https://doi.org/10.1016/0959-8049(92)90136-p
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Intravenous ciprofloxacin as empirical treatment of febrile neutropenic patientsThe American Journal of Medicine, 1989
- Vancomycin, Ticarcillin, and Amikacin Compared with Ticarcillin-Clavulanate and Amikacin in the Empirical Treatment of Febrile, Neutropenic Children with CancerNew England Journal of Medicine, 1988
- Comparison of cefoperazone and mezlocillin with imipenem as empiric therapy in febrile neutropenic cancer patientsThe American Journal of Medicine, 1988
- Randomized trial of beta-lactam regimens in febrile neutropenic cancer patientsThe American Journal of Medicine, 1988
- Empirie Antibacterial Therapy in Granulocytopenia Induced by Cancer ChemotherapyAnnals of Internal Medicine, 1988
- Ceftazidime Combined with a Short or Long Course of Amikacin for Empirical Therapy of Gram-Negative Bacteremia in Cancer Patients with GranulocytopeniaNew England Journal of Medicine, 1987
- Empirical Antimicrobial Therapy in the Neutropenic HostNew England Journal of Medicine, 1986
- A Randomized Trial Comparing Ceftazidime Alone with Combination Antibiotic Therapy in Cancer Patients with Fever and NeutropeniaNew England Journal of Medicine, 1986
- Risk factors and comparisons of clinical nephrotoxicity of aminoglycosidesThe American Journal of Medicine, 1986
- Neutropenia, fever, and infectionThe American Journal of Medicine, 1984